Information Procurement 1.5.1
7.6 A Phase II Clinical Trial Testing Liraglutide in AD As a result of the neuroprotective effects of liraglutide that we observed in animal models of AD [193], we obtained funding for a randomized, placebo-controlled, double-blind phase II clinical trial testing liraglutide in 204 participants with mild AD (NCT01843075) (the ELAD study) [194]
How to Start Your Routine If youre new to this combination, don't feel the need to jump to the highest dose immediately
We recommend: Morning: Apple Stem Cell Serum Night: Copper Peptide Serum This alternating approach supports hydration, firmness, antioxidant protection, and radiance without overwhelming sensitive skin
Existing extended-release options, like weekly formulations of semaglutide and dulaglutide, have reduced injection frequency, and future innovations may include monthly formulations or implantable devices that deliver continuous therapy
Most BPC-157 safety data comes from animal research